MAP Papers Archives - Crohn's MAP Vaccine

A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn’s disease

A message from Amy. I’m delighted to share...

Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn’s Disease through Downregulation of NF-κB Activation in the Absence of MAP Detection

We are delighted to share a new paper from Naser...

Anti-Mycobacterial Antibiotic Therapy Induces Remission in Active Paediatric Crohn’s Disease

This is the latest paper from Dr Agrawal and...

Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series

Another paper from Borody et al on the use...

Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn’s Disease: A Case Series

In this recent paper from Professor Thomas...

Presence of MAP Monitored Over Varying Temporal and Spatial Scales in River Catchments: Persistent Routes for Human Exposure

This recent study from Pickup et al provides...

Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’sdisease

This paper from Naser et al supports genotype...

Chronic regional intestinal inflammatory disease: A trans-species slow infection?

A new paper from Juste et al in Spain, which...